All Stories

  1. Effect of benzo(a)pyrene on oxidative stress and inflammatory mediators in astrocytes and HIV-infected macrophages
  2. Differential packaging of inflammatory cytokines/ chemokines and oxidative stress modulators in U937 and U1 macrophages-derived extracellular vesicles upon exposure to tobacco constituents
  3. Nanotechnology approaches for delivery of cytochrome P450 substrates in HIV treatment
  4. Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment
  5. Choosing the right pharmacotherapeutic strategy for HIV maintenance in patients with alcohol addiction
  6. The dawn of precision medicine in HIV: state of the art of pharmacotherapy
  7. Potential neuroprotective role of astroglial exosomes against smoking-induced oxidative stress and HIV-1 replication in the central nervous system
  8. Recent advances in cancer outcomes in HIV-positive smokers
  9. Kinetic characterizations of diallyl sulfide analogs for their novel role as CYP2E1 enzyme inhibitors
  10. Chronic Effects of Ethanol and/or Darunavir/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and Cytotoxicity
  11. Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1
  12. Drug–drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems